Joint Relief Institute
Joint Relief Institute is a privately held outpatient healthcare provider operating five clinics in Illinois and Minnesota, delivering non-surgical fluoroscopy-guided hyaluronic acid gel injections for knee and shoulder osteoarthritis, primarily billed to Medicare and commercial insurers.
- Company typePrivate
- Founded2015
- HeadquartersOak Brook, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Joint Relief Institute does
Joint Relief Institute is a privately held, founder-owned outpatient healthcare provider founded in 2015 by Dr. Michael Hana, MD. The company specializes in non-surgical treatment of chronic knee and shoulder osteoarthritis using fluoroscopy-guided viscosupplementation (FDA-approved hyaluronic acid gel injections), offering 12 gel formulations to tailor therapy to individual patient anatomy and disease severity. Live X-ray imaging is used during each procedure to confirm needle placement directly into the joint space, which the company markets as a precision differentiator versus blind injection.
The company operates five physical clinic locations: four in Illinois (Glenview, Oak Brook, Orland Park, and Chicago/Stony Island) and one in Minnesota (Edina), serving patients from the Chicago and Minneapolis metros. Treatment is delivered in-office in approximately 15-20 minutes with no downtime, and the typical course consists of 3-5 injections per joint with effects reported to last 6-12 months. Since inception the organization has treated 40,000+ patients and administered 400,000+ injections, maintaining a 4.9 average rating across 5,000+ verified Google and Facebook reviews.
Revenue is generated on a fee-for-service basis, billing Medicare Part B, Medicare Advantage plans (BCBS MA, Wellcare, Zing Health, Devoted Health, Ascension Complete), Medigap supplements, and major commercial carriers (BCBS, UnitedHealthcare, Aetna, Humana, Cigna, plus 300+ additional plans). Approximately 93% of insured visits and 98.5% of Medicare visits result in little to no out-of-pocket cost to the patient, while self-pay pricing is positioned at $300-$800 per injection. Patient acquisition is direct-to-consumer, using TV advertising, organic search, YouTube testimonials, BBB accreditation, patient referrals, and an in-house inside-sales team that runs a sub-2-minute phone verification and a self-serve online booking flow; the site is available in English, Polish, and Spanish.
Joint Relief Institute firmographics
Firmographics- Name
- Joint Relief Institute
- Legal name
- Joint Relief Institute
- Website
- https://jointreliefinstitute.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Joint Relief Institute is a privately held outpatient healthcare provider operating five clinics in Illinois and Minnesota, delivering non-surgical fluoroscopy-guided hyaluronic acid gel injections for knee and shoulder osteoarthritis, primarily billed to Medicare and commercial insurers.
- Ownership category
- akta.pro rank
Joint Relief Institute industry classification
Industry- Product category
- Orthopedic Pain Management
- NAICS
- Offices of Physicians (6211), Other Ambulatory Health Care Services (6219)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Hip & Knee Reconstruction (Arthroplasty) (HLAKALAH)
Keywords
Where Joint Relief Institute is headquartered
LocationHeadquarters
- HQ city
- Oak Brook
- HQ country
- United States
- HQ region
- North America
Offices5 records
Markets served
Joint Relief Institute business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Marketing or Sales, Operations, Technology or R&D, Infrastructure, Supply Chain
Revenue model
- Medical Procedure Fees: Fee-for-service revenue from viscosupplementation injection procedures. Revenue is generated through direct billing to Medicare Part B and private insurance plans. Self-pay options available at $300-$800 per injection for uninsured patients.
- Insurance Reimbursement: Primary revenue stream from Medicare Part B (covering 80% of approved amounts), Medicare Advantage plans, Medicare Supplement (Medigap) plans, and commercial insurance including BCBS, Aetna, UnitedHealthcare, Humana, Cigna, and 300+ other plans. Self-pay and payment plan options also available.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Medicare patients typically pay $0-$50 per injection |
| Other | Pay-as-you-go | Private insurance patients - 89% pay $0 |
| Unit Pricing | Pay-as-you-go | Self-pay patients: $300-$800 per injection |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
Joint Relief Institute product offering
Product offeringCore offering
Joint Relief Institute provides in-office, non-surgical viscosupplementation treatments using FDA-approved hyaluronic acid gel injections delivered through fluoroscopy-guided precision placement to relieve chronic knee and shoulder osteoarthritis pain. The procedure is a 15-20 minute outpatient alternative to joint replacement surgery, typically administered as a series of 3-5 injections per treatment cycle and covered by Medicare Part B and most major private insurance plans.
Product overview
Joint Relief Institute offers a unified non-surgical joint pain treatment platform centered on FDA-approved hyaluronic acid gel injection therapy (viscosupplementation) for knee and shoulder osteoarthritis. The core offerings are Knee Gel Injections and Shoulder Gel Injections, both delivered using proprietary Fluoroscopy-Guided Injection Technology for precision placement. Supporting services include Insurance Verification and Online Appointment Scheduling. All treatments are performed in-office with no downtime and are covered by Medicare and most insurance plans.
Differentiator
Problem solved
Functional benefit
Products and services
- Knee Gel Injections
Quantifiable outcome
- 90% of patients report noticeable joint pain relief
- +5 more outcomes
Companies that use Joint Relief Institute
Customer profileNamed customers8 records
Segments4 records
Ideal customer profiles4 records
Joint Relief Institute technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Joint Relief Institute partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core.
- MedicarecoreMedicare Part B covers viscosupplementation (knee gel injections) when medically necessary for osteoarthritis. Medicare pays 80% after deductible. Medigap supplements often cover remaining 20%, resulting in $0 patient cost for most beneficiaries. Shoulder gel injections are off-label and not covered by Medicare but are covered by most private insurance.
- Blue Cross Blue ShieldcoreMajor commercial insurance provider accepted at Joint Relief Institute. BCBS plans typically cover knee and shoulder gel injections. Most BCBS patients have paid $0 out-of-pocket for treatment.
- UnitedHealthcarecoreMajor commercial insurance provider accepted at Joint Relief Institute. Coverage varies by plan with most patients paying minimal out-of-pocket costs.
- AetnacoreMajor commercial insurance provider accepted at Joint Relief Institute. Coverage varies by plan.
- HumanacoreMajor commercial insurance provider accepted at Joint Relief Institute. Coverage varies by plan.
- CignacoreMajor commercial insurance provider accepted at Joint Relief Institute. Coverage varies by plan.
- Medicare Advantage PlanscoreMedicare Advantage plans including BCBS MA, Wellcare, Zing Health, Devoted Health, Ascension Complete accepted. Coverage varies by plan. 93% of Medicare Advantage patients have paid $0 out-of-pocket.
Scale indicators8 records
Recent moves7 records
Expansion highlights6 records
Joint Relief Institute competitors and assessment
Company assessmentEmerging players
- Sword Health: Virtual-first MSK care provider combining digital exercise therapy with clinician oversight for joint and back pain. Competes for the same surgery-avoidance demand via a different (digital) delivery channel and an employer/payer GTM motion.
- Hinge Health: Digital musculoskeletal-care platform delivering virtual PT, exercise therapy, and education for joint pain, increasingly contracted through employers and health plans. Reaches a partially overlapping patient (knee/hip OA) via a non-in-person, software-led delivery model that could substitute for some JRI demand.
Direct peers
- QC Kinetix: Fast-growing franchise chain of non-surgical regenerative-medicine clinics (PRP and other biologics) targeting joint pain in active adults and Medicare-age patients. Directly competes for the same 'avoid surgery' patient with a similar D2C, multi-clinic, multi-state playbook.
- Healeon Medical: Non-surgical joint-pain treatment clinics offering viscosupplementation and related injection therapies, with a similar D2C, multi-location model targeting the surgery-averse, Medicare-eligible patient.
- Arthritis Knee Pain Centers: Specialty clinic network delivering viscosupplementation and related non-surgical therapies for knee osteoarthritis using imaging guidance. Competes for the same Medicare-aged patient seeking a non-surgical alternative to knee replacement.
- Osteo Relief Institute: Multi-location D2C clinic chain offering non-surgical viscosupplementation injections for knee osteoarthritis using fluoroscopic guidance. Nearly identical clinical, GTM, and payer model to Joint Relief Institute, including TV-led patient acquisition and a Medicare-focused patient mix.
- Regenexx: Network of clinics offering image-guided, non-surgical orthopedic treatments (including bone-marrow concentrate and PRP) for joint pain. Overlaps JRI on the precision-injection, surgery-avoidance positioning and Medicare/commercial payer footprint.
Broad incumbents
- Cleveland Clinic (Orthopedic & Rheumatology): Large academic health system with a high-volume orthopedic and rheumatology service line that includes non-surgical OA management and joint injection therapy. Sets the clinical standard JRI is benchmarked against but operates a hospital-based, broad-portfolio model rather than a focused D2C clinic chain.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Joint Relief Institute social profiles
Digital presenceJoint Relief Institute compliance and trust
Trust signalCompliance2 records
Joint Relief Institute financial estimates
Financial estimateRevenue estimate
Valuation estimate
Joint Relief Institute leadership team
Management profileNumber of profiles
Profiles5 records
Joint Relief Institute funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Joint Relief Institute M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Joint Relief Institute
What does Joint Relief Institute do?
Joint Relief Institute provides in-office, non-surgical viscosupplementation treatments using FDA-approved hyaluronic acid gel injections delivered through fluoroscopy-guided precision placement to relieve chronic knee and shoulder osteoarthritis pain. The procedure is a 15-20 minute outpatient alternative to joint replacement surgery, typically administered as a series of 3-5 injections per treatment cycle and covered by Medicare Part B and most major private insurance plans.
Is Joint Relief Institute a public or private company?
Joint Relief Institute is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Joint Relief Institute founded?
Joint Relief Institute was founded in 2015. It employs 11 to 50 people.
Where is Joint Relief Institute based?
Joint Relief Institute is headquartered in Oak Brook, United States, in the North America region.
How does Joint Relief Institute make money?
Two revenue lines are on record. Medical Procedure Fees are the primary driver. The others are insurance Reimbursement.
Who are Joint Relief Institute's main competitors?
Emerging players on record are Sword Health and Hinge Health. Direct peers are QC Kinetix, Healeon Medical, Arthritis Knee Pain Centers, Osteo Relief Institute and Regenexx. Cleveland Clinic (Orthopedic & Rheumatology) is listed as a broad incumbent.
Does Joint Relief Institute have an API?
No public API is recorded for Joint Relief Institute.
What industry is Joint Relief Institute in?
Joint Relief Institute's product category is Orthopedic Pain Management. Its primary akta.pro industry code is HLAKALAH, Hip & Knee Reconstruction (Arthroplasty). Its NAICS code is 6211 and its SIC code is 8011.